Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

3D spheroid culture makes stem cells better at reducing inflammation.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

Proton minibeam radiotherapy may reduce skin side effects by causing localized DNA damage.

Low-frequency electromagnetic fields may help hair growth by affecting certain growth-related molecules.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Recognizing specific markers is crucial for correctly diagnosing and treating rare multifocal MPTT in males.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Heat-killed Enterococcus faecalis EF-2001 may promote hair growth and transition hair follicles to the growth phase.

Erdr1 could be a new marker for diagnosing hair loss.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Certain signals are important for reducing specific chemical markers on hair follicle stem cells during rest periods, which is necessary for healthy hair growth.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

A machine learning model can predict alopecia areata early using specific gene markers.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Recurrent pneumothorax can occur in Sjogren's syndrome, even without common markers.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

Early diagnosis using eye tests and lab markers can improve treatment for pediatric Sjögren's syndrome.